Bausch + Lomb Corp - Understand $blco stock

$BLCO Market Cap: $6.531 Billion

Research Board Inbox Deep Research Not Interested Shortlisted

Financial Snapshot

Revenue

$4.495B

TTM

Gross Margin

60.87%

TTM

Net Earnings

-$456.0M

TTM

Current Assets

$2.769B

Q2 2024

Current Liabilities

$1.676B

Q2 2024

Current Ratio

165.21%

Q2 2024

Total Assets

$13.25B

Q2 2024

Total Liabilities

$6.670B

Q2 2024

Book Value

$6.580B

Q2 2024

Cash

$285.0M

Q2 2024

P/E

-14.32

Sep 17, 2024 EST

Free Cash Flow

-$137.0M

TTM

Revenues

Revenue YoY Change

Revenues

Concept	2023	2022	2021	2020	2019	2018
Revenue	$4.146B	$3.768B	$3.765B	$3.412B	$3.778B	$3.665B
YoY Change	10.03%	0.08%	10.35%	-9.69%	3.08%

Expenses

Cost Of Revenues

Gross Profit

Gross Profit Margin

Gross Profit

Concept	2023	2022	2021	2020	2019	2018
Revenue	$4.146B	$3.768B	$3.765B	$3.412B	$3.778B	$3.665B
Cost Of Revenue	$1.642B	$1.519B	$1.467B	$1.285B	$1.327B	$1.313B
Gross Profit	$2.504B	$2.249B	$2.298B	$2.127B	$2.451B	$2.352B
Gross Profit Margin	60.4%	59.69%	61.04%	62.34%	64.88%	64.17%

Selling, General & Admin Expense

Research & Development

Depreciation, Depletion & Amortization

SGA Expense to Gross Profit Ratio

R&D To Gross Profit Ratio

DDA To Gross Profit Ratio

Operating Expenses Total

Operating Profits/Loss

Operational Expenses

Concept	2023	2022	2021	2020	2019	2018
Selling, General & Admin	$1.736B	$1.478B	$1.389B	$1.253B	$1.382B	$1.327B
YoY Change	17.46%	6.41%	10.85%	-9.33%	4.14%
% of Gross Profit	69.33%	65.72%	60.44%	58.91%	56.39%	56.42%
Research & Development	$324.0M	$307.0M	$271.0M	$253.0M	$258.0M	$221.0M
YoY Change	5.54%	13.28%	7.11%	-1.94%	16.74%
% of Gross Profit	12.94%	13.65%	11.79%	11.89%	10.53%	9.4%
Depreciation & Amortization	$142.0M	$135.0M	$415.0M	$442.0M	$469.0M	$495.0M
YoY Change	5.19%	-67.47%	-6.11%	-5.76%	-5.25%
% of Gross Profit	5.67%	6.0%	18.06%	20.78%	19.14%	21.05%
Operating Expenses	$2.060B	$1.785B	$1.956B	$1.858B	$2.015B	$1.896B
YoY Change	15.41%	-8.74%	5.27%	-7.79%	6.28%
Operating Profit	$130.0M	$207.0M	$342.0M	$269.0M	$436.0M	$456.0M
YoY Change	-37.2%	-39.47%	27.14%	-38.3%	-4.39%

Interest Expenses

Interest Expenses To Operating Income %

Other Expense/Income

Interest & Other Expense/Income

Concept	2023	2022	2021	2020	2019	2018
Interest Expense	-$296.0M	-$134.0M	-$11.00M	$30.00M	$3.000M	$1.000M
YoY Change	120.9%	1118.18%	-136.67%	900.0%	200.0%
% of Operating Profit	-227.69%	-64.73%	-3.22%	11.15%	0.69%	0.22%
Other Income/Expense, Net	-$74.00M	-$13.00M	-$17.00M	-$38.00M
YoY Change	469.23%	-23.53%	-55.26%

Income/Loss

Pretax Income

Income Tax

Net Profits/Loss

Pretax Income YoY Change

Income Tax Rate

Net Profits/Loss YoY Change

Basic EPS

Net Income To Revenue Ratio

Pretax & Net Income

Concept	2023	2022	2021	2020	2019	2018
Pretax Income	-$166.0M	$73.00M	$318.0M	$290.0M	$399.0M	$417.0M
YoY Change	-327.4%	-77.04%	9.66%	-27.32%	-4.32%
Income Tax	$82.00M	$58.00M	$125.0M	$307.0M	$96.00M	-$302.0M
% Of Pretax Income		79.45%	39.31%	105.86%	24.06%	-72.42%
Net Earnings	-$260.0M	$6.000M	$182.0M	-$18.00M	$298.0M	$710.0M
YoY Change	-4433.33%	-96.7%	-1111.11%	-106.04%	-58.03%
Net Earnings / Revenue	-6.27%	0.16%	4.83%	-0.53%	7.89%	19.37%
Basic Earnings Per Share	-$0.74	$0.02	$0.52	-$0.05
Diluted Earnings Per Share	-$0.74	$0.02	$520.0K	-$51.43K	$851.4K	$2.029M

Assets & Liabilities

Cash & Short-Term Investments

Cash & Equivalents

Cash To Operating Expenses Ratio

Inventory

Receivables

Total Short-Term Assets

Property, Plant And Equipment

Long-Term Investments

Total Long-Term Assets

Total Assets

Net Income To Total Assets Percentage

Accounts Payable

Short-Term Debt

Long Term Debt Due

Total Short-Term Liabilities

Long-Term Debt

Other Long-Term Liabilities

Total Long-Term Liabilities

Total Liabilities

Short-Term To Long-Term Debt Ratio

Short-Term Assets To Debt Ratio

Long-Term Debt To Net Income Ratio

Assets & Liabilities

Concept	2023	2022	2021	2020	2019
Cash & Short-Term Investments	$331.0M	$354.0M	$174.0M	$238.0M	$192.0M
YoY Change	-6.5%	103.45%	-26.89%	23.96%
Cash & Equivalents	$331.0M	$354.0M	$174.0M	$238.0M	$192.0M
Short-Term Investments
Other Short-Term Assets	$544.0M	$431.0M	$168.0M	$155.0M	$198.0M
YoY Change	26.22%	156.55%	8.39%	-21.72%
Inventory	$1.028B	$628.0M	$572.0M	$616.0M	$592.0M
Prepaid Expenses
Receivables	$839.0M	$724.0M	$721.0M	$645.0M	$713.0M
Other Receivables	$0.00	$0.00	$0.00	$0.00	$0.00
Total Short-Term Assets	$2.742B	$2.137B	$1.635B	$1.654B	$1.695B
YoY Change	28.31%	30.7%	-1.15%	-2.42%
Property, Plant & Equipment	$1.504B	$1.419B	$1.337B	$1.264B	$1.090B
YoY Change	5.99%	6.13%	5.78%	15.96%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$1.032B	$1.023B	$1.001B	$1.101B	$1.274B
YoY Change	0.88%	2.2%	-9.08%	-13.58%
Total Long-Term Assets	$10.70B	$9.007B	$9.188B	$9.612B	$9.773B
YoY Change	18.8%	-1.97%	-4.41%	-1.65%
Total Assets	$13.44B	$11.14B	$10.82B	$11.27B	$11.47B
YoY Change
Accounts Payable	$522.0M	$370.0M	$239.0M	$178.0M	$262.0M
YoY Change	41.08%	54.81%	34.27%	-32.06%
Accrued Expenses	$627.0M	$493.0M	$516.0M	$454.0M	$472.0M
YoY Change	27.18%	-4.46%	13.66%	-3.81%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$30.00M	$25.00M
YoY Change	20.0%
Total Short-Term Liabilities	$1.579B	$1.296B	$1.099B	$909.0M	$1.035B
YoY Change	21.84%	17.93%	20.9%	-12.17%
Long-Term Debt	$4.532B	$2.411B	$0.00	$0.00	$0.00
YoY Change	87.97%
Other Long-Term Liabilities	$397.0M	$329.0M	$298.0M	$342.0M	$363.0M
YoY Change	20.67%	10.4%	-12.87%	-5.79%
Total Long-Term Liabilities	$4.929B	$2.740B	$298.0M	$342.0M	$363.0M
YoY Change	79.89%	819.46%	-12.87%	-5.79%
Total Liabilities	$6.592B	$4.111B	$1.494B	$1.348B	$1.509B
YoY Change	60.35%	175.17%	10.83%	-10.67%

Ownership

Basic Shares Outstanding

Diluted Shares Outstanding

Preferred Stock

Treasury Stock Shares

Stock Issuance & Repurchase

Ownership Data

Concept	2023	2022	2021	2020
Basic Shares Outstanding	350.5M shares	350.0M shares	350.0M shares	350.0M shares
Diluted Shares Outstanding	350.5M shares	350.2M shares	350.0M shares	350.0M shares
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Book Value

Free Cash Flow

Free Cash Flow YoY

Dividends

Stock Price

Market Cap: $6.5312 Billion

About Bausch + Lomb Corp

Bausch + Lomb Corp. develops, manufactures, and markets eye health products. The company is headquartered in Vaughan, Ontario and currently employs 13,300 full-time employees. The company went IPO on 2022-05-06. The company operates in three segments: Vision Care, Pharmaceuticals, and Surgical. The Vision Care segment includes both a contact lens and a consumer eye care business that consists of contact lens care products, over-the-counter eye drops and eye vitamins. The Pharmaceuticals segment consists of generic pharmaceutical products for post-operative treatments and treatments for a number of eye conditions, such as glaucoma, eye inflammation, ocular hypertension, dry eyes and retinal diseases. The Surgical segment consists of medical device equipment, consumables, instruments and technologies for the treatment of cataracts, corneal and vitreous and retinal eye conditions, which includes delivery systems, phacoemulsification equipment and other surgical instruments and devices for cataract surgery. Its brands consist of PreserVision, Biotrue, Artelac, Alaway, Mioclear, Ocuvite, XIIDRA, Vyzulta, Lotemax, Prolensa, Minims, INFUSE, and many more.

Industry: Ophthalmic Goods Peers: